Gu, Yue
Shunmuganathan, Bhuvaneshwari
Qian, Xinlei
Gupta, Rashi
Tan, Rebecca S. W.
Kozma, Mary
Purushotorman, Kiren
Murali, Tanusya M.
Tan, Nikki Y. J.
Preiser, Peter R.
Lescar, Julien
Nasir, Haziq
Somani, Jyoti
Tambyah, Paul A.
Fong, Siew-Wai
Amrun, Siti Naqiah
Goh, Yun-Shan
Tay, Matthew Zi-Rui
Rouers, Angeline
Chang, Zi Wei
Yeo, Nicholas Kim-Wah
Chan, Yi-Hao
Hor, Pei Xian
Loh, Chiew Yee
Yang, Yuling
Ruesta, Anthony Torres
Neo, Vanessa
Chen, Wendy Yehui
Goh, Estelle Yi-Wei
Ong, Alice Soh-Meoy
Chua, Adeline Chiew Yen
Nguee, Samantha
Tang, Yong Jie
Tang, Weiyi
Wong, Joel Xu En
Smith, Kenneth G. C.
Renia, Laurent
Ng, Lisa F. P.
Lye, David C.
Young, Barnaby E.
MacAry, Paul A.
,
Article History
Received: 21 May 2023
Accepted: 6 December 2023
First Online: 9 December 2023
Competing interests
: The ELISA-based surrogate viral neutralisation test has been commercialized and branded by GENY BIOLOGICS as the ImTracker MULTI COVID-19 viral variant neutralisation test (ExternalRef removed). The following authors are co-inventors: Paul A. MacAry, Bhuvaneshwari Shunmuganathan, Rashi Gupta and Gu Yue. The remaining authors do not have any competing interests to declare.